RQC-23945-08372
2 vaccinations
2 coded responses
6 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 680 / NE
- Registered
- 2022-12-17
- Relationship
- Child or adolescent in my care
- Guardian
- 7JA-26782-39603
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-12-16
Dose 1 — Pfizer-BioNTech
-
2022-12-17
Registered in v-safe
-
2022-12-17
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-12-18
-
2023-01-15
Survey response — day 28, dose 1, under 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
-
2023-01-20
Dose 2 — Pfizer-BioNTechCo-administered: Flu:Pneumonia
-
2023-01-21
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Site: Pain · Irritability/cryingUnder 3 check-in
-
2023-01-22
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
-
2023-02-03
Survey response — day 14, dose 2, under 3MedDRA: Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-03
Report sent to call center — day 14, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-02-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-12-16 | Pfizer-BioNTech | No |
| 2 | 2023-01-20 | Pfizer-BioNTech | Flu:Pneumonia |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-02-03 | Unsuccessful |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release